-
International collaboration yields insights into childhood leukemia risk
11/25/2019
Researchers know that different biology underlies CLL and ALL. However, there may be a link between the two diseases.
-
St. Jude researchers among the most highly cited in 2019
11/22/2019
Nearly 20 scientists from St. Jude Children's Research Hospital named Highly Cited Researchers for 2019 by the Web of Science group.
-
Gene therapy for X-linked SCID wins 2019 Smithsonian Magazine American Ingenuity Award
11/19/2019
Gene therapy developed by the late Brian Sorrentino honored by Smithsonian Magazine.
-
Understanding transporter proteins at a single-molecule level
11/13/2019
Research co-led by a St. Jude investigator and researchers from Columbia University and the New York State Psychiatric Institute reveals the mechanics of how some transporter proteins function with stunning specificity.
-
Chemotherapy sometimes sets the stage for drug-resistant leukemia at relapse
11/01/2019
An International collaboration has identified therapy-induced, drug-resistance mutations in children with acute lymphoblastic leukemia who relapse.
-
Treating the TOTAL patient: clinical trial reduces relapse
10/28/2019
Researchers at St. Jude have announced results of the Total Therapy Study 16 clinical trial, which tested strategies for lowering the rate of relapse of acute lymphoblastic leukemia in children from 2007–2017.
-
Controlling the immune system’s brakes to treat cancer, autoimmune disorders
10/24/2019
St. Jude researchers have discovered two enzymes that may have a crucial role in treating autoimmune disorders and certain cancers.
-
Exercise may give the brain a boost
10/21/2019
A St. Jude study reveals more about the link between cancer survivors’ physical fitness and their thinking and learning skills.
-
Childhood cancer survivorship data portal in St. Jude Cloud launched at ASHG
10/18/2019
A St. Jude Children’s Research Hospital online portal into pediatric cancer survivorship data debuts at the American Society of Human Genetics annual meeting.
-
Pharmacogenetics of thiopurine and NUDT15 mutations presented at ASHG
10/18/2019
Researchers have uncovered a relationship between the gene NUDT15 and how thiopurine drugs function. These findings support the use of NUDT15 to guide thiopurine dose to limit treatment related toxicity.
Explore more research news
More Research News
-
Scientific Report 2019
The Scientific Report, Translating Science into Survival, describes key breakthroughs made by St. Jude investigators.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Promise Magazine
Courageous patients. Resolute doctors. Caring staff. Inventive scientists. Their voices come alive in Promise magazine.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.